ArticleBlood research2026

Exploring CD79b, LC3, and TERT expression in NON-GCB DLBCL: markers associated with Rituximab-Cyclophosphamide-Doxorubicin-Vincristin-Prednisone treatment response.

Bethy S Hernowo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.